CardioGenics Holdings (CardioGenics Holdings) Earnings per Share (Diluted) : $-0.01 (TTM As of Jan. 2016)

CardioGenics Holdings Earnings per Share (Diluted) Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Earnings per Share (Diluted)		Get a 7-Day Free Trial					-0.11	-0.02	-0.05	-0.04	-0.02

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-0.01	-	-0.01	-	-

Competitive Comparison of CardioGenics Holdings's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, CardioGenics Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's PE Ratio falls into.

CardioGenics Holdings Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

CardioGenics Holdings's Earnings Per Share (Diluted) for the fiscal year that ended in Oct. 2015 is calculated as

CardioGenics Holdings's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2016 is calculated as

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

CardioGenics Holdings  (OTCPK:CGNH) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CardioGenics Holdings Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description